Catalyst Wire Dossier Catalyst Wire Dossier

Sevacizumab

sevacizumab · Jiangsu Simcere Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sevacizumab, covering 2015-03-24 to 2016-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer [Phase 1]

See pricing